science wire

Up to 30,000 healthcare workers from across the globe will be recruited to participate in a clinical trial co-led by UCL, which aims to establish whether chloroquine, a widely prescribed anti-malaria drug, could also prevent people from getting COVID-19.

University of Minnesota Medical School researchers have launched two new clinical trials to test whether the blood pressure medication losartan can prevent lung injury in people recently diagnosed with COVID-19.

University of Sussex researchers have joined an international team of volunteer chemists aiming to deliver a drug candidate effective against COVID-19.

In a piece for The Conversation, Dr Qasim Rafiq and Professor Martina Micheletti (UCL Biochemical Engineering) describe the challenges of quickly ramping up production of a coronavirus vaccine.

MIT Environment, Health and Safety Office responds to national shortage by producing, testing, and distributing its own product for the MIT community.

Researchers are driving forward the fight against coronavirus with new healthcare innovations and data insights. Research projects funded by Imperial's donor-backed COVID-19 Response Fund include those advancing new technologies and using cutting edge data science to find ways for health services worldwide to respond to the crisis.

Associate Professor Qasim Rafiq and Professor Martina Micheletti (UCL Biochemical Engineering) comment on the challenges involved in the manufacturing process as the world races to develop a vaccine for Covid-19.

The risk of blood clots following surgery is the same whether patients wear compression stockings or not, a new trial has found.

For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.

A Cardiff University-led review is being used globally to inform pioneering use of lung ultrasound to help in the management of patients with Covid-19.

Citizen scientists across the UK are being urged to map bee-friendly plants using a Spot-a-Bee app developed in Wales and Scotland.

Paper co-authored by MIT economist proposes a new way to handle medical shortages during the Covid-19 crisis.

A UK trial of drugs which could prevent people aged over 50 who are vulnerable to developing serious coronavirus symptoms is now recruiting participants from across the country.

Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.

For humans, the Covid-19 virus is a novel foe. And to combat a new pathogen, we need innovation: a new vaccine, new drugs, new tests, new clinical knowledge, and new data for epidemiology models.

FACULTY Q&A In late April, the federal government announced Operation Warp Speed, an aggressive COVID-19 vaccine development program that aims to have at least 300 million doses of vaccine available in the United States by January.

"We found a patient's response to the antibiotic improved significantly if the dosage was monitored and altered accordingly," Dr Abdul-Aziz said.

EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The startup they created, called Flowbone, has just made it through the second round of the Venture Kick competition. Femoral neck fractures occur frequently among the elderly, and are usually caused by osteoporosis - a disease that weakens the bone structure.

Scientists are launching a major new research project in India that will help to engineer an efficient and sustainable delivery mechanism - ready to get an eventual COVID-19 vaccine to billions of people around the globe.

Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology .

Snow Medical has announced a $5.5m gift to the Universities of Sydney and Melbourne to plug coronavirus research gaps and fast-track economic recovery.

As the public looks for treatments for SARS-CoV-2, some businesses in the United States are marketing unlicensed and unproven stem-cell-based "therapies" and exosome products that claim to prevent or treat the disease.

The Universities of Glasgow and Dundee have been awarded £225,000 to rapidly screen for potential COVID-19 treatments.

Stanford Medicine researchers who participated in two separate clinical trials are encouraged by data indicating that remdesivir can treat COVID-19.

Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.

One-of-a-kind clinic provides hope for treatment of hoarding disorder Climbing the steep gravel path to Ri Parrish's house, a serene, empty silence hovers above the stark vistas surrounding the property, dotted and perfumed by occasional pine trees.

Cosentyx is the first fully-human IL-17A inhibitor indicated for patients in Europe with non-radiographic axial spondyloarthritis (nr-axSpA), which forms part of the axial spondyloarthritis (axSpA) d

The University of Queensland 's COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing.

The University of Glasgow has been awarded more than £1m from the Scottish Government to undertake nine crucial COVID-19 research projects.

Vendors on the dark web are selling Personal Protective Equipment (PPE) and drugs marketed as coronavirus vaccines or cures at high cost, according to a new study from The Australian National University (ANU).

Isolated COVID-19 patients benefit from interaction via iPad in Stanford Health Care's Marc and Laura Andreessen Emergency Department.

Editor ' s note: To read more about how UChicago is on the frontlines of the coronavirus pandemic, visit the  Confronting COVID-19 website.

Imperial has announced the winners of the first round of funding for projects tackling the coronavirus pandemic.

In response to a lack of potential coronavirus medications on the market, pharmacists from the University of Basel have begun to produce tablets themselves.